A group of hackers is looking for information related to drug safety, clinical trials, regulatory decisions and legal issues that's significant enough to move the global financial markets--and it's raiding top pharma execs' email accounts to find it, The New York Times reports. Using tailored emails and Wall Street vernacular, the attackers dupe victims into clicking on links or attachments that redirect them to a fake email login page designed to steal their credentials. More (sub. req.)